Consent and compliance

Fentanyl drug testing for employers: do employment drug tests detect it, and DOT's status (2026)

On this page
  1. Do employment drug tests detect fentanyl?
  2. Which drug testing programs include fentanyl in 2026?
  3. Why is fentanyl not on the DOT panel yet?
  4. What should staffing agencies do about fentanyl testing?
  5. How can a non-DOT employer add fentanyl to its drug test?
  6. What about candidates who take prescribed fentanyl?
  7. What should recruiters and hiring managers do now?
  8. Questions people ask

Most employment drug tests do not detect fentanyl unless the employer orders a panel that includes it. HHS added fentanyl (and its metabolite norfentanyl, in urine) to the federal workplace drug testing panels effective July 7, 2025, but DOT has only proposed the same change: as of November 2026 the DOT panel in 49 CFR 40.85 still has no fentanyl, and DOT laboratories may not test DOT specimens for it. Non-DOT employers can add fentanyl to their own panels, subject to state rules on notice and medical review.

For the rest of the DOT rulebook, see DOT drug testing requirements for employers; to write the panel into a policy, use the drug testing policy template.

Not legal advice. Checked as of November 2026 against eCFR (Title 49, current to November 10, 2026), the Federal Register, the Unified Agenda entry for DOT's rule and the state statutes linked below. DOT could publish a final rule at any time; check the Federal Register before relying on this page.

Do employment drug tests detect fentanyl?

Only if fentanyl is on the panel. Fentanyl is a synthetic opioid, and it is a separate analyte from the opioids most panels test (codeine, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone and the heroin marker 6-acetylmorphine). When HHS added it to the federal panels, its January 16, 2025 notice (90 FR 4662) said a commenter had "incorrectly stated" that fentanyl would be detected and reported by the current opioid tests for federal agency urine specimens. HHS also explained why it had not added fentanyl earlier: in 2015 fentanyl was mostly found mixed with heroin, which the 6-acetylmorphine test already caught, but illicit fentanyl is now increasingly used on its own.

Which drug testing programs include fentanyl in 2026?

ProgramFentanyl tested?Status as of November 2026Source
Federal agency workplace programs (HHS Mandatory Guidelines)Yes, urine and oral fluidAdded effective July 7, 2025; HHS's March 13, 2026 notice made no changes and kept the panels in effect90 FR 4662; 91 FR 12308
DOT-regulated testing (FMCSA, FAA, FRA, FTA, PHMSA, USCG)NoProposed September 2, 2025; comments closed October 17, 2025; final rule "To Be Determined"49 CFR 40.85; 90 FR 42363; RIN 2105-AF26
Non-DOT employer programsOnly if the employer orders itSet by the employer's policy and laboratory order, within state lawState statutes below

The HHS fentanyl cutoffs

These apply to federal agency programs and are the reference point most laboratories use when they offer fentanyl testing to private employers. From the HHS panels in 90 FR 4662:

SpecimenInitial testConfirmatory test
UrineFentanyl, 1 ng/mL (the immunoassay must have at least 5% cross-reactivity to norfentanyl)Fentanyl 1 ng/mL; norfentanyl 1 ng/mL
Oral fluidFentanyl, 4 ng/mLFentanyl, 1 ng/mL

HHS kept MDMA and MDA on the panels in the same notice, after proposing to remove them.

Why is fentanyl not on the DOT panel yet?

DOT must follow HHS's scientific guidelines, but a change to the HHS panel reaches DOT testing only after DOT finishes its own rulemaking, as DOT itself explained in its September 2, 2025 proposal. That proposal would add fentanyl and norfentanyl to Part 40, harmonize other laboratory provisions with the HHS guidelines and make technical amendments. As of November 2026:

  • The cutoff table in 49 CFR 40.85 lists marijuana, cocaine, codeine and morphine, hydrocodone and hydromorphone, oxycodone and oxymorphone, 6-acetylmorphine, phencyclidine, amphetamines and MDMA/MDA, and no fentanyl.
  • The Federal Register shows no final rule; DOT's later 2026 Part 40 rules dealt with substance abuse professionals (March 4) and observed urine collections in place of oral fluid (May 11).
  • DOT's Unified Agenda entry lists the rule as a long-term action, with the final rule date "To Be Determined".

Until a final rule takes effect, a DOT employer cannot add fentanyl to a DOT test. Laboratories must test DOT specimens for the five drug classes and "must not test" them for any other drugs (40.82), and Part 40 forbids testing a DOT specimen for additional drugs (40.13(c)). An employer that wants fentanyl results for a DOT-covered applicant would need a separate non-DOT test under its own authority, on a separate specimen collected after the DOT test, with its own non-federal form.

If DOT finalizes the rule as proposed, the change will come through the laboratory tables rather than anything the employer files: the proposal's revised 40.85 (urine) and 40.91 (oral fluid) tables use the same fentanyl cutoffs as HHS, shown above. Once a final rule is published, check your DOT policy and the educational materials FMCSA employers must give drivers (49 CFR 382.601) against the new panel and its effective date.

What should staffing agencies do about fentanyl testing?

  • Read the client's panel request against the job. A client may ask for a "DOT panel plus fentanyl" for drivers. For DOT-covered drivers the DOT test cannot include fentanyl, so any fentanyl result would come from a separate company test, collected and reported apart from the DOT test.
  • Use the worksite state's notice rules. If the panel changes, the candidate notice must change with it in states that require the drugs to be listed, such as Hawaii and Vermont.
  • Keep results with the employer of record. The agency that orders the test receives the verified result; share only what the client needs to decide the placement. More on roles and costs is in drug testing for staffing agencies.

How can a non-DOT employer add fentanyl to its drug test?

  1. Order a panel that includes it. Ask the laboratory which fentanyl analytes and cutoffs it uses (for example, whether norfentanyl is confirmed in urine, as HHS requires) and whether the same panel is available for every specimen type you use.
  2. Check instant devices. FDA classifies fentanyl test systems as opiate test systems under 21 CFR 862.3650, and its October 6, 2026 order confirms that those labeled solely for employment and insurance testing are exempt from premarket review. A non-negative screen still needs laboratory confirmation; see instant drug tests vs lab tests.
  3. Put it in writing. List fentanyl in the policy's panel and in the notice the candidate gets before collection. In Hawaii, the written statement given before collection must list the specific substances, and no laboratory or on-site location may test for anything not on it (HRS 329B-5(a), (c)). In Vermont, an applicant's written notice must list the drugs to be tested and state that therapeutic levels of prescribed drugs will not be reported (21 V.S.A. 512(b)(2)).
  4. Use medical review. Fentanyl is also a prescription medicine. An MRO, not the recruiter, should contact the candidate about a laboratory positive.
  5. Apply it the same way to every candidate for the role. Minnesota, for example, requires the same test of all applicants conditionally offered the position (Minn. Stat. 181.951, subd. 2).

What about candidates who take prescribed fentanyl?

The ADA does not protect an applicant who is currently engaging in the illegal use of drugs (42 U.S.C. 12114(a)), and a test for illegal drug use is not a medical examination (12114(d)). But "illegal use of drugs" does not include drugs taken under the supervision of a licensed health care professional (42 U.S.C. 12111(6)), so a lawful prescription is a disability-law question, not a drug-policy one. The EEOC's pre-employment guidance allows an employer to ask about lawful drug use to validate a positive test, not before. In DOT testing the MRO handles this through the verification interview (40.137). Safety concerns about a lawfully prescribed medicine in a safety-sensitive job are handled separately; see non-DOT drug testing for safety-sensitive jobs and pre-employment medical exams and the ADA.

What should recruiters and hiring managers do now?

  • Do not tell DOT applicants they will be tested for fentanyl; under current Part 40 they will not be.
  • For non-DOT roles, decide with HR whether fentanyl belongs on the panel and for which positions, then update the policy, the candidate notice (see the drug testing consent form template) and the laboratory order together.
  • Treat a fentanyl screen like any other result: pending until confirmed and, where used, verified by the MRO. The next steps after a verified positive are in what to do when a candidate fails a pre-employment drug test.
  • Watch the Federal Register for a final DOT rule under RIN 2105-AF26; when one is published, its effective date controls when DOT panels change.

State rules on how tests must be run (laboratories, confirmation, notice) apply to a fentanyl test as to any other; compare them in drug testing laws in hiring.

Questions people ask

Does a standard pre-employment drug test detect fentanyl?

Usually not. Fentanyl is detected only when the panel includes a fentanyl test. The DOT panel in 49 CFR 40.85 does not include it as of November 2026, and HHS noted when it added fentanyl to the federal workplace panels that the existing opioid tests do not detect and report fentanyl in federal agency urine specimens.

Is fentanyl on the DOT drug test panel in 2026?

No. DOT proposed adding fentanyl and norfentanyl to 49 CFR Part 40 on September 2, 2025 (90 FR 42363), but as of November 2026 the cutoff table in 40.85 on eCFR has no fentanyl, the Unified Agenda lists the final rule date as to be determined, and a DOT specimen may not be tested for any drug outside the panel.

Can a private employer add fentanyl to its pre-employment drug test?

Usually yes, for non-DOT jobs, by ordering a panel that includes fentanyl and listing it in the written policy and candidate notice. Some states fix the panel through the notice: Hawaii bars testing for any substance not on the written statement given before collection, and Vermont requires the notice to list the drugs tested.

What happens if a candidate has a fentanyl prescription?

A Medical Review Officer reviews the laboratory positive and can verify it as negative when the candidate shows a legitimate medical explanation such as a valid prescription. The ADA does not protect current illegal drug use, but drugs taken under the supervision of a licensed health care professional are not illegal use, so recruiters should leave medication questions to the MRO.